Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
MapLight Therapeutics, Inc. ( (MPLT) ) has issued an announcement.
MapLight Therapeutics, Inc. successfully closed its initial public offering (IPO) on October 28, 2025, issuing 14,750,000 shares of common stock at $17.00 per share, with underwriters exercising an option to purchase an additional 2,212,500 shares. Concurrently, the company completed a private placement with Goldman Sachs affiliates, raising gross proceeds of $296.3 million from both the IPO and private placement, which will enhance its financial position and market presence.
More about MapLight Therapeutics, Inc.
For detailed information about MPLT stock, go to TipRanks’ Stock Analysis page.